Healthy volunteers test heart drug interactions in early-stage trial
NCT ID NCT07431866
First seen Mar 15, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This early-stage study in 39 healthy adults checks if a new heart failure medicine called MK-2828 affects how the body handles two common drugs: rosuvastatin and furosemide. The goal is to gather safety and interaction data, not to treat any disease. Participants must be in good health with a BMI between 18 and 32.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fortrea Clinical Research Unit Inc ( Site 0001)
RECRUITINGDaytona Beach, Florida, 32117, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.